Climb Bio (CLYM) Change in Acquisitions & Divestments (2022 - 2026)

Climb Bio has reported Change in Acquisitions & Divestments for 5 years, with the latest figure at $31.9 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Acquisitions & Divestments rose 99.37% year-over-year to $31.9 million; the trailing twelve-month figure through Mar 2026 stood at $127.0 million (up 452.18% YoY), and the FY2025 full-year result was $111.1 million, up 435.41% from the prior year.
• Change in Acquisitions & Divestments for Q1 2026 stood at $31.9 million, up from $30.5 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $55.3 million in Q3 2022, with the low at $7.0 million in Q4 2024.
• Historically, Change in Acquisitions & Divestments has averaged $27.6 million across 5 years, with a median of $25.5 million in 2025.
• Annual changes were most pronounced in 2024 — Change in Acquisitions & Divestments slumped 80.95% — and 2025, when it soared 336.26%.
• Climb Bio's Change in Acquisitions & Divestments stood at $21.0 million in 2022, then jumped by 75.06% to $36.7 million in 2023, then tumbled by 80.95% to $7.0 million in 2024, then jumped by 336.26% to $30.5 million in 2025, then rose by 4.47% to $31.9 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $31.9 million (Q1 2026), $30.5 million (Q4 2025), and $39.1 million (Q3 2025), per Business Quant data.